Alnylam Pharmaceuticals
ALNY
#446
Rank
S$67.89 B
Marketcap
S$513.95
Share price
-2.02%
Change (1 day)
56.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company